An adaptive two-stage design with treatment selection using the conditional error function approach

Biometrical Journal

Volumn 48, Issue 4, 2006, Pages 679-689

  Wang, Jixian ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adaptive design; Conditional error function; Optimal design; Treatment selection

Indexed keywords

ERRORS;

ADAPTIVE DESIGNS; CONDITIONAL ERROR FUNCTION; ERROR-FUNCTION; FUNCTION APPROACHES; OPTIMAL DESIGN; PHASE II; SAMPLE SIZES; TREATMENT SELECTION; TWO STAGE DESIGNS; TYPE-I ERROR;

OPTIMAL SYSTEMS;

EID: 33748558786     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200510236     Document Type: Article

References (24)

1. Bauer, P. and Kieser, M. (1999). Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 18, 1833-48.
2. Brannath, W. and Bauer, P. (2004). Optimal conditional error function for the control of conditional power. Biometrics 60, 715-720.
3. Bischoff, W. and Miller, F (2005). Adaptive two-stage procedures to find the best treatment in clinical trials. Biometrika 92, 197-212.
4. Brannath, W. Posch, M. and Bauer, P. (2002). Recursive comination tests. Journal of the American Statistical Association 97, 236-244.
5. Clyde, M. A. and Chaloner, K. (1996). The equivalence of constrained and weighted designs in multiple objective design problems. Journal of the American Statistical Association 91, 1236-1244.
6. Jennison, C. and Turnbull, B. W. (2005). Meta-analyses and adaptive group sequential designs in the clinical development process. Journal of Biopharmaceutical Statistics 15, 537-558.
7. Fox, C. (1963). An Introduction to the Calculus of variations. Oxford University Press, Oxford.
8. Kelly, P., Stallard, N., and Todd, S. (2005). An adaptive group sequential design for phase II/III clinical trials that select a single treatment from several. Journal of Biopharmaceutical Statistics 15, 641-658
9. Koyama T., Sampson A. R., and Gleser L. J. (2005). A Calculus for Design of Two-Stage Adaptive Procedures, Journal of the American Statistical Association 100, 197-203.
10. Lehmacher, W. and Wassmer, G. (1999). Adaptive sample size calculation in group sequential trials. Biometrics 55, 1286-1290.
11. Liu, Q. and Chi, G. Y. (2001). On sample size and inference for two-stage adaptive designs. Biometrics 57, 172-177.
12. Lui, Q. and Pledger, G. W. (2005). Phase 2 and 3 combination designs to accelerate drug development. Journal of the American Statistical Association 100, 493-501.
13. Müller, H. H. and Schäfer, H. (2001). Adaptive group sequential designs for clinical trials: Combining the advantages of adaptive and of classical group sequential procedures. Biometrics 57, 886-891.
14. Posch M. and Bauer, P. (1999). Adaptive two stage designs and the conditional error function. Biometrical Journal 41, 689-696.
15. Posch, M., Bauer, P. and Brannath, W. (2003). Issues in designing flexible trials. Statistics in Medicine 22, 953-969.
16. Posch, M., König F., Branson, M., Brannath W., Dunger-Baldauf C. and Bauer, P. (2005). Testing and estimation in flexible group sequential designs with adaptive treatment selection. Statistics in Medicine 24, 3697-3714.
17. Proschan, M. A. (2003). The geometry of two-stage tests. Statistica Sinica 13, 163-177.
18. Proschan, M. A. and Hunsberger, S. A. (1995). Designed extension of studies based on conditional power. Biometrics 51, 1315-1324.
19. R Development Core Team (2005). R: A language and environment for statistical computing. R Foundation for Statistical Computing. http://www.R-project.org.
20. Sampson, A. and Sill, M. W. (2005). Drop-the-losers design: normal case, (with discussions). Biometrical Journal 47, 257-268.
21. Schäfer, H. and Müller, H. H. (2004). Construction of group sequential designs in clinical trials on the basis of detectable treatment differences. Statistics in Medicine 23, 1413-1424.
22. Stallard, N. and Todd, S. (2003). Sequential designs for phase in clinical trials incorporating treatment selection. Statistics in Medicine 22, 689-703.
23. Thach, C. and Fisher, L. D. (2002). Self-designing two-stage trials to minimize expected costs. Biometrics 58, 432-438.
24. Thall, P., Simon, R. and Ellenberg, S. S. (1989). A two-stage design for choosing among several experimental treatments and a control in clinical trials. Biometrics 45, 537-547.